Inozyme Pharma, Inc.·4

Jan 14, 4:19 PM ET

Jungles Steven J 4

4 · Inozyme Pharma, Inc. · Filed Jan 14, 2021

Insider Transaction Report

Form 4
Period: 2021-01-13
Jungles Steven J
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2021-01-13+44,31544,315 total
    Exercise: $2.77Exp: 2030-04-22Common Stock (44,315 underlying)
Footnotes (1)
  • [F1]This option was granted on April 23, 2020, with vesting subject to the satisfaction of performance based vesting criteria. The performance based vesting criteria were satisfied on January 13, 2021 and the shares underlying the option vest in equal monthly installments from April 23, 2020 through April 23, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION